Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00419588 · ClinicalTrials.gov registry record
Growth of Airways and Lung Tissues in Premature and Healthy Infants
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 184
- Enrollment target
NCT00419588: Completed study, sponsored by Indiana University.
NCT00419588 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 184 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00419588 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 184 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the growth of the lung and how easily gas can be taken up by the lung in healthy infants born at full term without any breathing problems and infants born prematurely.
Primary Outcome
Forced Expiratory flows, single breath diffusion capacity and alveolar volume
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 184 participants |
| Start Date | 2006-09 |
| Est. Completion | 2019-01 |
What the finished NCT00419588 record still lists
NCT00419588 is an observational study that tracks outcomes without assigning an intervention. The registered 184 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00419588 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00419588 about?
NCT00419588 is a clinical study titled "Growth of Airways and Lung Tissues in Premature and Healthy Infants". The purpose of this study is to evaluate the growth of the lung and how easily gas can be taken up by the lung in healthy infants born at full term without any breathing problems and infants born prematurely.
What is the current status of trial NCT00419588?
This trial is currently completed. The enrollment target is 184 participants. The study started on 2006-09. Estimated completion is 2019-01.
Who is sponsoring clinical trial NCT00419588?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03903510 · 184 participants · NA
Virtual Reality During Pediatric Cast Removal
- NCT04020510 · 184 participants · Phase 4
Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive Bladder
- NCT04135846 · 184 participants · Phase 2
Alpha-1 Blockade for Alcohol Use Disorder (AUD)
- NCT04396873 · 184 participants · Phase 1
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia